Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mintel Watching For Mood-Enhancing Beauty, Nature/Science Fusions In 2010

Executive Summary

Impacted by the economic recession, consumers are looking for personal-care products that offer protection and maybe even lift their spirits, Mintel suggests in its predictions for 2010
Advertisement

Related Content

Market Visionaries Predict Trends for 2011, Including "Natural Shakedown"
Market Visionaries Predict Trends for 2011, Including "Natural Shakedown"
Consumers Drawn To "Healthy Halo" Of Naturals, But Unsure Of Efficacy
Consumers Drawn To "Healthy Halo" Of Naturals, But Unsure Of Efficacy
Professional Hair-Care Sector Not Ready To Cut Out Synthetics
Professional Hair-Care Sector Not Ready To Cut Out Synthetics
Consumers staying true to organics
FDA Cites Latisse Web Site For Implying Eyelash Growth Drug Is A Cosmetic
Jan Marini Ceases Eyelash Product Sales Due To Allergan Suit, FDA Threat
Jan Marini Ceases Eyelash Product Sales Due To Allergan Suit, FDA Threat
Advertisement
UsernamePublicRestriction

Register

RS016641

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel